← Open Payments lookup

JIANPING CHEN: Open Payments

NPI 1245229814 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300,444 in 467 payments from 12 companies in 2025. Trend: 2023 $238,675 · 2024 $236,138 · 2025 $300,444

Speaker / faculty: $208,650Honoraria: $37,775Consulting: $20,224Travel & lodging: $20,091Food & beverage: $13,602Education: $101
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.68$63,393
Teva Pharmaceuticals USA, Inc.61$57,830
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)70$44,948
Axsome Therapeutics, Inc.61$42,035
E.R. Squibb & Sons, L.L.C.51$30,635
Otsuka America Pharmaceutical, Inc.39$26,205
Alkermes, Inc.33$23,281
ABBVIE INC.27$10,552
Neurocrine BioSciences, Inc.41$1,217
Lundbeck LLC11$192

Products named: FANAPT, CAPLYTA, Auvelity, UZEDY, LYBALVI, REXULTI, COBENFY, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.